Medical Device Network

Medical Device Network Excellence Awards 2025: Penumbra

Penumbra is a leading thrombectomy and embolization company and a Dual Category Award Winner in the 2025 Medical Device Network Excellence Awards Penumbra’s launch of the Ruby ® XL peripheral ...
MarketWatch

First Surgery With Polymer-Based Coil Takes Place, Using Embolization, Inc., Device

BOULDER, Colo., Nov. 10, 2025 /PRNewswire/ -- A woman in Delaware has become the first patient to undergo minimally invasive, endovascular surgery with a polymer-based coil. The coil, manufactured by ...
jnis.bmj

Supply cost and outcome comparison of nBCA, Onyx, and coils for middle meningeal artery embolizations: a single-center retrospective analysis

Background Middle meningeal artery (MMA) embolization is increasingly utilized in the treatment of chronic subdural hematoma (cSDH); however, supply cost variation between embolization agents remains ...
Endovascular Today

Penumbra’s Ruby XL System Cleared by FDA for Peripheral Embolization

June 5, 2025—Penumbra, Inc. announced the FDA clearance and launch of the Ruby XL system, part of the company’s Ruby portfolio of peripheral embolization products. According to Penumbra, the Ruby XL, ...
jnis.bmj

Endovascular coil embolization through a previously implanted Contour intrasaccular device for recurrent posterior communicating artery aneurysm

Intrasaccular flow diverters such as the Contour Neurovascular System represent a significant advancement in the endovascular management of intracranial aneurysms, particularly those with complex ...